Healthcare

Why Celyad Oncology (CYAD) stocks rally on Friday?
December 04, 2021 07:36 AM AEDT| By Versha JainHighlights The stocks of Celyad Oncology (CYAD) were up over 45% on Friday morning. Fortress Investment invested US$32.5 million in Celyad through a private placement. Fortress purchased 6.5 million shares of Celyad’s common stocks. .....

Longeveron Inc (LGVN) stock’s record rally continues - Know why?
December 04, 2021 06:24 AM AEDT| By Versha JainHighlights Longeveron Inc. (NASDAQ: LGVN) stock rallied on Friday as its common stock offering in a private placement draws to a close. Longeveron Inc. had launched its IPO in February 2021. The LGVN stock gained 218% since the launch. It rose.....

Cumberland (CPIX) stock jumped 100% today – Here’s why
December 01, 2021 07:07 AM AEDT| By Versha JainHighlights Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) stock soared more than 100% on Tuesday. The biotechnology company grew by 55% YTD. FDA has approved expanded labeling of its pain reliever injection for pre-operative administratio.....

HCA Healthcare, Inc. (HCA) stock price, YTD gain – among top performers
December 01, 2021 06:47 AM AEDT| By Sanjeeb BaruahHighlights The HCA Healthcare, Inc. stock gained nearly 40% this year. The stock’s 52-week highest and the lowest stock prices were US$263.92 and US$148.92, respectively. The Nashville, Tennessee-based company on Tuesday announced plans t.....

First Wave BioPharma (FWBI) stock soars over 36% on upbeat trial data
December 01, 2021 04:11 AM AEDT| By Versha JainThe First Wave BioPharma, Inc. (NASDAQ: FWBI) stock rose more than 36% in the premarket on Tuesday after announcing the data monitoring committee’s (DMA) decision to continue enrollment of its Reservoir Phase 2 trials for covid-related g.....

Five hot healthcare stocks to watch as Omicron threat looms
November 30, 2021 08:58 AM AEDT| By Versha JainHighlights The Florida-based NRX Pharmaceuticals, Inc. develops novel therapeutics for central nervous system disorders and life-threatening pulmonary diseases. The Pennsylvania-based Krystal Biotech, Inc. develops treatments for skin diseases......

Why is Allied Healthcare (AHPI) stock up 53% Friday?
November 27, 2021 08:17 AM AEDT| By Rupam RoyHighlights Stocks of Allied Healthcare Products rallied over 53% in the premarket on Friday. WHO is likely to convene to discuss the spread of a new Covid variant in South Africa. The AHPI stock price surged over 4% YTD. Stocks of Allied .....

Guess why Moderna (MRNA) stock jumped 23% Friday?
November 27, 2021 06:56 AM AEDT| By Rupam RoyHighlights Moderna’s covid vaccine was found to be most effective among four other drugs in a study. Its vaccine had an effectiveness of 88.8% against covid infection and 93.6% against covid-related deaths. The MRNA stock price grew over.....

Biofrontera stock (BFRI) rallies 115%, fired up by upbeat rating
November 25, 2021 05:50 AM AEDT| By Rupam RoyHighlights Analysts raised the 12-month stock price target to US$20. The BFRI jumped 115% in intraday trading after the positive comments. The Massachusetts-based company specializes in dermatology drugs and medical cosmetics, mainly for skin .....

Ocuphire Pharma (OCUP) stock jumped 34% - know why?
November 25, 2021 03:39 AM AEDT| By Rupam RoyHighlights Ocuphire Pharma announced the number of participants for the MIRA-3 Phase 3 trial. CEO Mina Sooch said the company will submit a new drug application (NDA) for Nyxol eye drops after the trial results. The company reported a net loss.....

Pasithea Therapeutics (KTTA) stock soars 229% - Know why?
November 24, 2021 07:29 AM AEDT| By Rupam RoyHighlights Pasithea Therapeutics' (KTTA) wholly-owned subsidiary Pasithea Clinics got approval for its anti-depressant esketamine nasal spray, SPRAVATO. The KTTA stock jumped over 229% in intraday trading on Tuesday. Currently, only three clin.....

Qualigen (QLGN) stock jumped 32% Tuesday – Is it worth the price?
November 24, 2021 06:27 AM AEDT| By Versha JainHighlights Qualigen Therapeutics, Inc. (NASDAQ: QLGN) soared 32% in intraday trading on Tuesday. Its third-quarter revenue rose to US$US$1.16 million compared to a net loss of US$8.11 million a year ago. The company develops novel therapeutic .....

Aadi Bioscience (AADI) stock soars on FDA approval for FYARRO
November 24, 2021 03:07 AM AEDT| By Rupam RoyHighlights Aadi Bioscience announced FDA approval for its injectable drug FYARRO. FYARRO is the only FDA-approved therapy for advanced malignant PEComa in adults. The AADI stock rose over 62% YTD. Shares of Aadi Bioscience, Inc. (NASDAQ: .....

Why is iSpecimen Inc. (ISPC) stock making headlines today?
November 23, 2021 05:26 AM AEDT| By Rupam RoyHighlights iSpecimen Inc. (ISPC) said that it secured a contract to support new research on covid. The stocks were up more than 130% on Monday morning. The company's revenue was up 21% YoY in Q3, FY21. The stocks of the online marketplace.....

Why ObsEva SA (OBSV) stock jumped on Monday?
November 23, 2021 04:08 AM AEDT| By Rupam RoyHighlights FDA has agreed to review the new drug application (NDA) for Linzagolix. It has set Sep 13, 2022, as a target date for the NDA review under the Prescription Drug User Fee Act (PDUFA). ObsEva announced the appointment of Stephanie Bro.....

Longeveron (LGVN) shares soared 138%, do you know why?
November 19, 2021 05:00 AM AEDT| By Rupam RoyHighlights FDA has granted rare-pediatric-disease (RPD) designation to Longeveron’s cellular therapy Lomecel-B. Longeveron is currently evaluating Lomecel-B in a Phase 2 trial. All the infants enrolled in its Lomecel-B Phase 1 trial were.....

Pfizer funding in Cardiff Oncology drives CRDF 21% higher. Know more
November 19, 2021 04:55 AM AEDT| By Versha JainHighlights Cardiff Oncology, Inc. (NASDAQ: CRDF) stock jumped 21% in premarket Thursday. The company has received a US$15 million equity investment from Pfizer Inc. Cardiff plans to use the proceeds for its ongoing clinical research in KRAS-mu.....

Dicerna-Novo Nordisk deal revealed: DRNA stock pops 78% in premarket
November 19, 2021 03:18 AM AEDT| By Versha JainHighlights Novo Nordisk will acquire Dicerna Pharmaceuticals for US$3.3 billion. After the acquisition, Novo expects to begin the clinical development of its first investigational therapeutic in 2022. The transaction, which would be de.....

Progenity (PROG) stock continues rally, up 21%: Here’s why
November 18, 2021 03:32 AM AEDT| By Raza NaqviHighlights Progenity, Inc. (NASDAQ: PROG) will participate in Piper Sandler 33rd Annual Virtual Healthcare Conference The company's revenue surged over 220% in Q3, FY21 PROG stocks were up more than 20% in pre-market trading today The sto.....

Why did Altamira Therapeutics (CYTO) stock skyrocket today?
November 13, 2021 07:29 AM AEDT| By Ipsita SarkarHighlights Altamira Therapeutics Ltd. (NASDAQ: CYTO) announces positive test results for Bentrio nasal spray. The company received FDA approval for Bentrio on Oct 14. Altamira’s operating loss was about US$7.01 million for the six months.....